Annual EBIT
-$10.96 M
+$2.90 M+20.92%
31 December 2023
Summary:
Qualigen Therapeutics annual earnings before interest & taxes is currently -$10.96 million, with the most recent change of +$2.90 million (+20.92%) on 31 December 2023. During the last 3 years, it has fallen by -$435.20 thousand (-4.14%). QLGN annual EBIT is now -4.14% below its all-time high of -$10.28 million.QLGN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$1.39 M
-$173.70 K-14.31%
30 September 2024
Summary:
Qualigen Therapeutics quarterly earnings before interest & taxes is currently -$1.39 million, with the most recent change of -$173.70 thousand (-14.31%) on 30 September 2024. Over the past year, it has increased by +$1.48 million (+51.60%). QLGN quarterly EBIT is now -379.74% below its all-time high of -$289.30 thousand, reached on 30 September 2019.QLGN Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$6.73 M
+$1.48 M+18.02%
30 September 2024
Summary:
Qualigen Therapeutics TTM earnings before interest & taxes is currently -$6.73 million, with the most recent change of +$1.48 million (+18.02%) on 30 September 2024. Over the past year, it has increased by +$4.51 million (+40.11%). QLGN TTM EBIT is now -1183.94% below its all-time high of -$524.40 thousand, reached on 30 June 2019.QLGN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
QLGN EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.9% | +51.6% | +40.1% |
| 3 y3 years | -4.1% | +71.1% | +62.6% |
| 5 y5 years | - | -379.7% | -727.5% |
QLGN EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -4.1% | +51.7% | -14.3% | +72.3% | at high | +70.3% |
| 5 y | 5 years | -4.1% | +51.7% | -379.7% | +92.5% | -727.5% | +79.3% |
| alltime | all time | -4.1% | +51.7% | -379.7% | +92.5% | -1183.9% | +79.3% |
Qualigen Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.39 M(+14.3%) | -$6.73 M(-18.0%) |
| June 2024 | - | -$1.21 M(-35.9%) | -$8.21 M(-19.1%) |
| Mar 2024 | - | -$1.89 M(-15.3%) | -$10.15 M(-7.3%) |
| Dec 2023 | -$10.96 M(-20.9%) | -$2.24 M(-22.0%) | -$10.95 M(-2.6%) |
| Sept 2023 | - | -$2.87 M(-9.1%) | -$11.24 M(-5.1%) |
| June 2023 | - | -$3.16 M(+17.3%) | -$11.84 M(-7.7%) |
| Mar 2023 | - | -$2.69 M(+6.3%) | -$12.83 M(-15.3%) |
| Dec 2022 | -$13.85 M | -$2.53 M(-27.1%) | -$15.15 M(-12.3%) |
| Sept 2022 | - | -$3.47 M(-16.2%) | -$17.27 M(-7.2%) |
| June 2022 | - | -$4.14 M(-17.3%) | -$18.61 M(-14.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$5.01 M(+7.8%) | -$21.86 M(-3.5%) |
| Dec 2021 | -$22.66 M(+115.4%) | -$4.65 M(-3.3%) | -$22.66 M(+25.8%) |
| Sept 2021 | - | -$4.81 M(-35.0%) | -$18.02 M(-15.5%) |
| June 2021 | - | -$7.39 M(+27.2%) | -$21.32 M(-34.3%) |
| Mar 2021 | - | -$5.81 M(-28.3%) | -$32.44 M(+21.8%) |
| Dec 2020 | -$10.52 M | - | - |
| Sept 2020 | - | -$8.11 M(-56.2%) | -$26.63 M(+41.6%) |
| June 2020 | - | -$18.52 M(+6302.0%) | -$18.81 M(+2211.7%) |
| Sept 2019 | - | -$289.30 K(-44.8%) | -$813.70 K(+55.2%) |
| June 2019 | - | -$524.40 K | -$524.40 K |
FAQ
- What is Qualigen Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Qualigen Therapeutics?
- What is Qualigen Therapeutics annual EBIT year-on-year change?
- What is Qualigen Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Qualigen Therapeutics?
- What is Qualigen Therapeutics quarterly EBIT year-on-year change?
- What is Qualigen Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Qualigen Therapeutics?
- What is Qualigen Therapeutics TTM EBIT year-on-year change?
What is Qualigen Therapeutics annual earnings before interest & taxes?
The current annual EBIT of QLGN is -$10.96 M
What is the all time high annual EBIT for Qualigen Therapeutics?
Qualigen Therapeutics all-time high annual earnings before interest & taxes is -$10.28 M
What is Qualigen Therapeutics annual EBIT year-on-year change?
Over the past year, QLGN annual earnings before interest & taxes has changed by +$2.90 M (+20.92%)
What is Qualigen Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of QLGN is -$1.39 M
What is the all time high quarterly EBIT for Qualigen Therapeutics?
Qualigen Therapeutics all-time high quarterly earnings before interest & taxes is -$289.30 K
What is Qualigen Therapeutics quarterly EBIT year-on-year change?
Over the past year, QLGN quarterly earnings before interest & taxes has changed by +$1.48 M (+51.60%)
What is Qualigen Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of QLGN is -$6.73 M
What is the all time high TTM EBIT for Qualigen Therapeutics?
Qualigen Therapeutics all-time high TTM earnings before interest & taxes is -$524.40 K
What is Qualigen Therapeutics TTM EBIT year-on-year change?
Over the past year, QLGN TTM earnings before interest & taxes has changed by +$4.51 M (+40.11%)